Eltropag 50mg Tablet
Marketer
Medicamen Biotech Ltd
Salt Composition
Eltrombopag (50mg)
Overview Eltropag 50mg Tablet
Romiplostim 50mg tablets are indicated for the management of low platelet counts stemming from chronic immune thrombocytopenic purpura (ITP) or chronic hepatitis C (HCV) infection. This medication also treats severe aplastic anemia. Acting as a thrombopoietin receptor agonist, Romiplostim 50mg stimulates platelet production, thereby lessening the risk of bleeding. Adhere strictly to your physician's prescribed dosage and regimen. Administration may be on an empty stomach. Swallow the tablet whole; avoid crushing, chewing, or breaking. Report any known drug allergies to your doctor. Commonly reported adverse effects include nausea, vomiting, diarrhea, upper respiratory infection, and urinary tract infection. Discuss any bothersome side effects with your doctor; management strategies may be available. Prior to commencing treatment, disclose all pre-existing medical conditions and medications to your physician. Dosage modifications might be necessary for individuals with liver impairment; consult your doctor.
Primary Ingredients of Eltropag 50mg Tablet
The provided text is "undefined," therefore, no rephrasing is possible.
Uses of Eltropag 50mg Tablet
Thrombocytopenia from immune thrombocytopenic purpura or hepatitis C; management of critical bone marrow failure
Major Benefits of Eltropag 50mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or breaking it. The Eltropag 50mg Tablet should be taken on an empty stomach.
Common Side effects of Eltropag 50mg Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Eltropag 50mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Eltropag 50mg Tablet on an empty stomach.
How Eltropag 50mg Tablet works:
Each 50mg Eltropag tablet contains a thrombopoietin receptor activator. Its mechanism of action involves boosting platelet production within the bloodstream. This increase in platelets aids in hemostasis, minimizing or averting hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Eltropag 50mg Tablets may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Eltropag 50mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Eltropag 50mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Eltropag 50mg Tablet, as dizziness and reduced alertness are potential side effects.
KidneySAFE IF PRESCRIBED
Eltropag 50mg tablets can be used by patients with kidney disease without a recommended dosage change. Nevertheless, kidney disease should be disclosed to your physician. Routine monitoring of kidney function is suggested during treatment with this medication.
LiverCAUTION
Patients with liver impairment should use Eltropag 50mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Eltropag 50mg Tablet :
Omit any missed Eltropag 50mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Eltropag 50mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Biphenyl Derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | Thrombopoietin stimulator |


